Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 601–700 of 999
Grupo de Trabajo de la SEC para la guía de la ESC sobre diabetes, P. Y. E. C. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.12.005 · Cited by 17
Formica, F., Gallingani, A., Tuttolomondo, D., Hernández‐Vaquero, D., Singh, G., Pattuzzi, C., Maestri, F., Niccoli, G., Ceccato, E., Lorusso, R., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101699 · Cited by 15
Chang, T., Hsu, C., Huang, P., Chiang, C.-H., Leu, H., Huang, C., Chen, J., & Lin, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.06.041 · Cited by 15
Fractional flow reserve-guided coronary bypass surgery
Ferguson, T. B., Chen, C., & Buch, A. N. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32836581a3 · Cited by 15
Coronary Artery Revascularization in Patients With Diabetes Mellitus
FITCHETT, D. H., Gupta, M., Farkouh, M. E., & Verma, S. (2014) · Circulation · doi:10.1161/circulationaha.113.007968 · Cited by 15
Self-citationNew Insights in the Diagnosis and Treatment of Heart Failure
Agnetti, G., Piepoli, M. F., Siniscalchi, G., & Nicolini, F. (2015) · BioMed Research International · doi:10.1155/2015/265260 · Cited by 18
The Evidence Base for Revascularisation of Chronic Total Occlusions
Bagnall, A. J., & Spyridopoulos, I. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x10666140331125659 · Cited by 15
“In the Freedom trial [26] comparing PCI with CABG in diabetic patients with multi-vessel disease, recruitment of 1900 patients took over 6 years from 140 centres.”
Mosleh, W., Sharma, A., Sidhu, M. S., Page, B. J., Sharma, U. C., & Farkouh, M. E. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6729-y · Cited by 16
Self-citationVaez, M., Dalén, M., Friberg, Ö., Nilsson, J., Fröbert, O., Lagerqvist, B., & Ivert, T. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcx007 · Cited by 15
Revascularization Strategies in Patients with Diabetes
Farkouh, M. E., DOMANSKI, M. J., & Fuster, V. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1301244 · Cited by 15
Self-citationShah, R., Yang, Y., Bentley, J. P., & Banahan, B. F. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1219708 · Cited by 14
Piperata, A., Busuttil, O., Jansens, J.-L., Modine, T., Pernot, M., & Labrousse, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111895 · Cited by 14
Caiazzo, G., Oliva, A., Testa, L., Heang, T. M., Lee, C. Y., Milazzo, D., Stefanini, G. G., Pesenti, N., Mangieri, A., Colombo, A., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02139-9 · Cited by 14
Yu, X., He, J., Luo, Y., Yuan, F., Song, X., Gao, Y., Li, Q., Huang, F.-J., Gu, C., Lv, S., et al. (2014) · International Heart Journal · doi:10.1536/ihj.14-193 · Cited by 14
Rodríguez, A. E., Palacios, I. F., Rodriguez-Granillo, A. M., Mieres, J., Tarragona, S., Fernández‐Pereira, C., Solórzano, L., Pauletto, R., Serruys, P. W. J. C., & Antoniucci, D. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.033 · Cited by 14
He, C., Lai, P., Wang, J., Zhou, T., Huang, Z., Zhou, L., & Liu, X. (2016) · Scientific Reports · doi:10.1038/srep27739 · Cited by 16
Perioperative Management of the Diabetic Patient Referred to Cardiac Surgery
Arthur, C. P. D. S., Mejía, O. A. V., Lapenna, G. A., Brandão, C. M. D. A., Lisboa, L. A. F., Dias, R. R., Dallan, L. A. O., Pomerantzeff, P. M. A., & Jatene, F. B. (2018) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2018-0147 · Cited by 17
Yager, N., Schulman‐Marcus, J., & Torosoff, M. T. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29368 · Cited by 14
“Furthermore, many (10–35%) high-risk individuals with multiple medical comorbidities were “screened-out” from these studies, leaving a paucity of evidence in certain patient cohorts.(5-8,18) We have investigated effects of procedurally complex coronary lesions, multivessel CAD, including LM disease, and comorbidities…”
BackgroundCarnero, M., Hernández‐Vaquero, D., Cubero-Gallego, H., Menéndez, J. L., Piñón, M., Martín, J. A., Caballero, G. C., Carnicer, J. C., Villamor-Jiménez, C., Forteza, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046141 · Cited by 14
Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?
Ofoegbu, C., & Manganyi, R. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x17666211027141043 · Cited by 15
Current Management of Sternal Wounds
Hamaguchi, R., Shekar, P. S., Johnson, J. A., & Orgill, D. P. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008510 · Cited by 14
Torregrossa, G., Sá, M. P., den Eynde, J. V., Sicouri, S., Wertan, M. C., Ramlawi, B., & Sutter, F. P. (2021) · Journal of Cardiac Surgery · doi:10.1111/jocs.16146 · Cited by 14
Lang, Q., Qin, C., & Meng, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.794925 · Cited by 14
“The exclusion criteria were as follows: (1) PCI for patients; (2) overlapping population; and (3) pediatric studies.”
BackgroundMethodInfluentialLeszek, A., Poli, L., Zbinden, S., Godoy, L. C., Reny, J., Farkouh, M. E., Charytan, D. M., & Mavrakanas, T. A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.02.023 · Cited by 14
Self-citationJin, Z., Xu, B., Yang, X., Jia, R., Meng, S., Hu, H., Deng, Y., Cao, X., Ruan, Y., Han, J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.044 · Cited by 14
Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies
Connelly, K. A., Advani, A., Advani, S. L., Zhang, Y., Kim, Y. M., Shen, V., Thai, K., Kelly, D. J., & Gilbert, R. E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0608-9 · Cited by 15
“These poor outcomes have dramatically impacted the appropriate management strategy of such individuals, with recent data demonstrating that coronary artery bypass grafting has superior outcomes to percutaneous coronary intervention in patients with diabetes and advanced coronary artery disease, albeit at a cost of inc…”
BackgroundKlima, U., Elsebaey, A. A., Gantri, M. R., Bongardt, J., Miller, G. A., & Emery, R. W. (2014) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-9-126 · Cited by 14
Risk stratification of patients undergoing medical therapy after coronary angiography
Bettinger, N., Palmerini, T., Caixeta, A. M., Dressler, O., Litherland, C., Francese, D. P., Giustino, G., Mehran, R., Leon, M. B., Stone, G. W., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv674 · Cited by 14
Landoni, G., Ломиворотов, В. В., Pisano, A., Neto, C. N., Benedetto, U., Biondi‐Zoccai, G., Gemma, M. F., Frassoni, S., Agrò, F. E., Baiocchi, M., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.05.011 · Cited by 15
Less-invasive coronary artery bypass grafting international landscape and progress
Kikuchi, K., & Mori, M. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000461 · Cited by 14
Left ventricular function recovery after revascularization
Ngu, J. M. C., Ruel, M., & Sun, L. Y. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000566 · Cited by 14
Chen, Y.-C., Lin, F., Lin, Y., Cheng, S., Lin, R.-H., Chuang, C., Sheu, J.-S., Chen, S.-M., Chang, C.-C., & Tsai, C. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0302-3 · Cited by 15
Kilic, A., Sultan, I. S., Gleason, T. G., Wang, Y., Smith, C., Marroquin, O. C., Thoma, F. W., Toma, C., Lee, J. S., & Mulukutla, S. R. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz336 · Cited by 15
Self-citationKosmopoulos, A., Verma, S., Meglis, G., Bhatt, D. L., Verma, R., Mazer, C. D., & Voisine, P. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000800 · Cited by 16
Zimmermann, F. M., Bruyne, B. D., Pijls, N. H. J., Desai, M., Oldroyd, K. G., Reardon, M. J., Wendler, O., Woo, Y.-P. J., Yeung, A. C., & Fearon, W. F. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.04.012 · Cited by 14
Aggarwal, B. K., Goel, S. S., Sabik, J. F., & Shishehbor, M. H. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.13030 · Cited by 17
The Proliferation of Scoring Systems
Fuster, V. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.017 · Cited by 14
“Their findings may question what was found in the FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) trial (5), wherein patients with diabetes benefited from coronary artery bypass surgery compared with medical therapy, regardless of the patient’s SYNTAX score.”
ResultSelf-citationCABG versus PCI — End of the Debate?
Welt, F. G. P. (2022) · New England Journal of Medicine · doi:10.1056/nejme2117325 · Cited by 14
Jaiswal, V., Sattar, Y., Ang, S. P., Ishak, A., Naz, S., NASIR, Y. M., Song, D. D., Titus, A., Huang, H. Y. R., Chaudhary, G. K., et al. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101185 · Cited by 21
Park, S., Park, S., & Park, D. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2022.0333 · Cited by 13
Stefil, M., Dixon, M. R., Benedetto, U., Gaudino, M. F. L., Lees, B., Gray, A. M., Gerry, S., Taggart, D. P., & Flather, M. D. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101235 · Cited by 16
Khorsandi, M., Blumenthal, R. S., Blaha, M. J., & Kohli, P. (2024) · Clinical Cardiology · doi:10.1002/clc.24284 · Cited by 14
“35,57,58 In patients with type 2 diabetes and multivessel coronary artery disease involving the left anterior descending artery (LAD), CABG is recommended over PCI, with an emphasis on using the left internal mammary artery graft to decrease the likelihood of death and the need for subsequent…”
BackgroundGiustino, G., & Dangas, G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.005 · Cited by 13
“the optimal initial revascularization modality in patients with multivessel CAD and DM.(8) However, previous to this trial, several other studies compared CABG with PCI as revascularization strategies in patients with CAD and DM.”
MethodResultInfluentialSelf-citationThe Cooperative Landscape of Multinational Clinical Trials
Hsiehchen, D., Espinoza, M., & Hsieh, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130930 · Cited by 15
Hlatky, M. A., Boothroyd, D. B., Baker, L. C., & Go, A. S. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.10.004 · Cited by 13
“DES for multivessel coronary disease (21).”
Shapira, O. M., Korach, A., Pinaud, F., Dabah, A., Bao, Y., Corbeau, J.-J., de Brux, J. L., & Baufreton, C. (2014) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-014-0196-3 · Cited by 13
Li, X.-M., Kong, M., Jiang, D., & Dong, A. (2013) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivt509 · Cited by 16
Chandrasekhar, J., Baber, U., Sartori, S., Aquino, M. B., Tomey, M. I., Kruckoff, M., Moliterno, D. J., Henry, T. D., Weisz, G., Gibson, C. M., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.049 · Cited by 13
“diabetes and predicted 30-day mortality [6-8].”
Self-citationBakaeen, F. G. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s4.04 · Cited by 14
Iglesias, J. F., Degrauwe, S., Rigamonti, F., Noble, S., & Roffi, M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1091-2 · Cited by 14
Re-evaluating the Role of CABG in Acute Coronary Syndromes
Farmer, D. M., & Jiménez, E. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01386-y · Cited by 17
Gioia, G. D., Flores, N. S., Franco, D., Colaiori, I., Sonck, J., Gigante, C., Kodeboina, M., Bartúnek, J., Vanderheyden, M., Praet, F. V., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009157 · Cited by 15
Suzuki, T., Asai, T., & Kinoshita, T. (2015) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivv234 · Cited by 13
“death and need for repeat revascularization [4].”
BackgroundInfluentialSheridan, W. S., Ryan, A. J., Duffy, G. P., O’Brien, F. J., & Murphy, B. P. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1063-z · Cited by 13
Stent selection to minimize the risk of stent thrombosis
Palmerini, T., Biondi‐Zoccai, G., & Stone, G. W. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000102 · Cited by 13
Pereira, H., Teles, R. C., Costa, M. A. D. S., da Silva, P. C., Ferreira, R. C., Ribeiro, V. D. G., de Oliveira, R. S., Abreu, P. F. E., Carvalho, H. C., Marques, J. H. S., et al. (2015) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2015.09.003 · Cited by 13
Jobs, A., & Thiele, H. (2015) · Herz · doi:10.1007/s00059-015-4369-1 · Cited by 13
The Effects of Diabetes Mellitus in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Liu, Y., Han, J., Liu, T., Yang, Z., Jiang, H., & Wang, H. (2016) · BioMed Research International · doi:10.1155/2016/4967275 · Cited by 15
“…Accepted 6 September 2016 Academic Editor: Francesco Onorati Copyright © 2016 Yu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is…”
BackgroundChang, M., Lee, C. W., Ahn, J., Cavalcante, R., Sotomi, Y., Onuma, Y., Park, D., Kang, S., Lee, S., Kim, Y., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.048 · Cited by 14
The future of off-pump coronary artery bypass grafting: a North American perspective
Yanagawa, B., Nedadur, R., & Puskas, J. D. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.10.07 · Cited by 13
Hawranek, M., Zembala, M. O., Gąsior, M., Hrapkowicz, T., Pyka, Ł., Cieśla, D., & Zembala, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25006 · Cited by 16
“Additionally, trials comparing CABG vs PCI in stable CAD rarely included patients with HFrEF [7, 8].”
BackgroundPercutaneous Coronary Intervention
Firouzi, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-51149-0.00020-1 · Cited by 13
Doulamis, I. P., Tzani, A. I., Tzoumas, A., Iliopoulos, D., Kampaktsis, P. Ν., & Briasoulis, Α. (2020) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2020.11.005 · Cited by 14
SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization
Lansky, A. J., Baron, S. J., Grines, C. L., Tremmel, J. A., Al-Lamee, R. K., Angiolillo, D. J., Chieffo, A., Croce, K., Jacobs, A. K., Madan, M., et al. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2021.100016 · Cited by 24
Self-citationMorton, J. I., Ilomäki, J., Wood, S. J., Bell, J. S., Huynh, Q. L., Magliano, D. J., & Shaw, J. E. (2022) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2021-218042 · Cited by 14
Myocardial Revascularisation in Renal Dysfunction: A Systematic Review and Meta-Analysis
Deo, S. V., Shah, I. K., Dunlay, S. M., Erwin, P. J., Dillon, J. M., & Park, S. J. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.03.005 · Cited by 13
Lu, D., Huang, C., Huang, P., Chen, J., Chen, T., Lin, S., Chan, W., Lee, C.-Y., & Leu, H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.035 · Cited by 13
Applicability of the COURAGE, BARI 2D, and FREEDOM Trials to Contemporary Practice
Bangalore, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.020 · Cited by 13
Rodríguez, A. E., Pavlovsky, H., & Pozo, J. F. D. (2016) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s40645 · Cited by 13
Boden, W. E., Caterina, R. D., & Taggart, D. P. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab445 · Cited by 13
Kawczynski, M. J., Gabrio, A., Maessen, J. G., Hof, A. W. J. V. ’., Brophy, J. M., Gollmann‐Tepeköylü, C., Nia, P. S., Vriesendorp, P. A., & Heuts, S. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.08.017 · Cited by 12
Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease
Posenau, J. T., WOJDYLA, D. M., Shaw, L. K., Alexander, K. P., Ohman, E. M., Patel, M. R., Smith, P. K., & Rao, S. V. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.10.053 · Cited by 12
Januszek, R., Dziewierz, A., Siudak, Z., Rakowski, T., Legutko, J., Rzeszutko, Ł., Kleczyński, P., Dudek, D., & Bartuś, S. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0102 · Cited by 12
Kwon, O., Park, D., & Park, S. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.12.038 · Cited by 12
Khan, M. R., Kayani, W. T., Pelton, J. E., Ansari, A. S., Paniagua, D. E., Khalid, U., Denktas, A. E., Changezi, H., Munir, A., Jiménez, E., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07063-0 · Cited by 12
Less invasive multivessel coronary artery bypass grafting: now is the time
Nambala, S., Mishra, Y. K., & Ruel, M. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000906 · Cited by 12
Lin, L., Ma, X., Kong, Q., Xiao, W. L., Liu, J., Chi, L.-Q., & Zhu, J. (2022) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-22-10 · Cited by 12
Shaik, T. A., Chaudhari, S. S., Haider, T., Rukia, R., Barznji, S. A., Kataria, H., Nepal, L., & Amin, A. (2022) · Cureus · doi:10.7759/cureus.29505 · Cited by 12
“Overall, 12 studies assessed all-cause mortality by enrolling 9,941 patients (4,954 treated with CABG and 4,987 with PCI) [3,4,7,13-21].”
BackgroundInfluential2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization
DEHMER, G. J., Grines, C. L., Bakaeen, F. G., Beasley, D. L., Beckie, T. M., Boyd, J. H., Cigarroa, J. E., Das, S. R., Diekemper, R. L., Frampton, J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.409 · Cited by 14
Coronary Artery Revascularization Evaluation—A Multicenter Registry With Seven Years of Follow‐Up
Kurlansky, P. A., Herbert, M. A., Prince, S. L., & Mack, M. J. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000162 · Cited by 12
Self-citationNyström, T., Holzmann, M. J., & Sartipy, U. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002411 · Cited by 13
Ferguson, T. B. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i11.623 · Cited by 12
Panvascular risk factor - Diabetes
Ramalingam, V., & Vijayvergiya, R. (2018) · Cor et Vasa · doi:10.1016/j.crvasa.2018.01.004 · Cited by 12
Timmis, A., Raharja, A., Archbold, A., & Mathur, A. (2018) · Heart · doi:10.1136/heartjnl-2018-313230 · Cited by 12
Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
Ungar, L. D. J., Sanders, D. S., Becerra, B., & Barseghian, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00116 · Cited by 12
Advances in Management of Stable Coronary Artery Disease: the Role of Revascularization?
Voudris, K. V., & Kavinsky, C. J. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0720-9 · Cited by 23
Hybrid Coronary Revascularization - Current State of the Art
Leyvi, G., Dabas, A., & Leff, J. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.08.047 · Cited by 12
Renal function and coronary bypass surgery in patients with ischemic heart failure
Doenst, T., Haddad, H. A., Stebbins, A. S., Hill, J. A., Velazquez, E. J., Lee, K. L., Rouleau, J. L., Sopko, G. S., Farsky, P. S., Al‐Khalidi, H. R., et al. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.02.136 · Cited by 16
EL‐Andari, R., Nagendran, J., Hong, Y., Ali, I. S., & Nagendran, J. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005513 · Cited by 12
Strategies for multivessel revascularization in patients with diabetes.
Lee, J.-H., & Lee, S.-W. (2013) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.13.21 · Cited by 197
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
Fearon, W. F., Zimmermann, F. M., & Pijls, N. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2202491 · Cited by 1
Optical Coherence Tomography — Light and Truth
Dauerman, H. L. (2023) · New England Journal of Medicine · doi:10.1056/nejme2309710 · Cited by 12
Ischemia Dictates Outcome, Not Symptoms
Stone, P. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.035 · Cited by 12
“If revascularization therapy is the preferred strategy in high-risk patients with diabetes and multivessel CAD, the recently reported FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease) trial indicated that CABG surgery reduced the rate of the pri…”
BackgroundTransit time flow measurement in arterial grafts
Leviner, D. B., Puskas, J. D., & Taggart, D. P. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-02670-6 · Cited by 11
“CABG has proven superior to percutaneous coronary intervention (PCI) in several patient groups including those with multivessel disease, those with diabetes, and those with left main disease [5, 6].”
BackgroundChoi, K. H., Park, T. K., Song, Y. B., Lee, J. M., Lee, J., Lee, S. J., Lee, S. Y., Kim, S.-M., Yun, K. H., Cho, J. Y., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17613 · Cited by 14
Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles
Fujita, J. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1490 · Cited by 11
Antagonist molecules in the treatment of angina
Gupta, A. K., Winchester, D. E., & Pepine, C. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.834329 · Cited by 12
“Surgical revascularization was in fact superior to percutaneous revascularization (BARI2D and FREEDOM) in reducing the death and MI in patients with diabetes [17-19,21] and those with severe left main, proximal LAD disease or high syntax score (SYNTAX) [22].”
MethodStents or surgery in coronary artery disease in 2013.
Taggart, D. P. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2225-319x.2013.07.20 · Cited by 11
“The debate over the relative efficacies of coronary artery bypass grafting (CABG) and stenting has recently been settled by the publication of the five-year outcomes of the SYNTAX and FREEDOM (in patients with diabetes) trials accompanied by supportive data from several large registries.”
BackgroundInfluentialManagement of the Patient With Diabetes and Coronary Artery Disease: A Contemporary Review
Raymond, T. E., Raymond, R. E., & Lincoff, A. M. (2013) · Future Cardiology · doi:10.2217/fca.13.22 · Cited by 11
Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?
Rodríguez, A. E., Fernández‐Pereira, C., Mieres, J., Mendoza, J., & Sartori, F. G. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0833-2 · Cited by 11
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.